| Year |
Citation |
Score |
| 2020 |
Chaturvedi NK, Kling MJ, Griggs CN, Kesherwani V, Shukla M, McIntyre EM, Ray S, Liu Y, McGuire TR, Sharp JG, Band H, Joshi SS, Coulter DW. A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma. Molecular Cancer Therapeutics. PMID 32371591 DOI: 10.1158/1535-7163.Mct-19-0996 |
0.329 |
|
| 2019 |
Song H, Bhakat R, Kling MJ, Coulter DW, Chaturvedi NK, Ray S, Joshi SS. Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy. Biochemical and Biophysical Research Communications. PMID 31594641 DOI: 10.1016/j.bbrc.2019.09.118 |
0.327 |
|
| 2018 |
Chaturvedi NK, Hatch ND, Sutton GL, Kling M, Vose JM, Joshi SS. A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib. Leukemia & Lymphoma. 1-10. PMID 30424705 DOI: 10.1080/10428194.2018.1520986 |
0.414 |
|
| 2018 |
Chaturvedi NK, Kling MJ, Coulter DW, McGuire TR, Ray S, Kesherwani V, Joshi SS, Sharp JG. Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy. Oncotarget. 9: 16619-16633. PMID 29682173 DOI: 10.18632/Oncotarget.24618 |
0.481 |
|
| 2017 |
Ray S, Coulter DW, Gray SD, Sughroue JA, Roychoudhury S, McIntyre EM, Chaturvedi NK, Bhakat KK, Joshi SS, McGuire TR, Sharp JG. Suppression of STAT3 NH2 -Terminal Domain Chemosensitizes Medulloblastoma Cells by Activation of Protein Inhibitor of Activated STAT3 via de-repression by MicroRNA-21. Molecular Carcinogenesis. PMID 29280516 DOI: 10.1002/Mc.22778 |
0.506 |
|
| 2017 |
Chaturvedi NK, Hatch ND, Sutton GL, Kling MJ, Vose JM, Joshi SS. Abstract 4051: Combination efficacy of HDAC inhibitor vorinostat and CDK-4/6 dual inhibitor palbociclib against therapy-resistant mantle cell lymphoma Cancer Research. 77: 4051-4051. DOI: 10.1158/1538-7445.Am2017-4051 |
0.5 |
|
| 2017 |
Chaturvedi NK, Coulter DW, McGuire TR, Kling MJ, Ray S, Joshi SS, Sharp JG. Abstract 161: Medulloblastoma therapy targeting Hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy Cancer Research. 77: 161-161. DOI: 10.1158/1538-7445.Am2017-161 |
0.342 |
|
| 2017 |
Ray S, Coulter DW, Gray SD, Sughroue JA, Chaturvedi NK, Joshi SS, Bhakat KK, McGuire TR, Sharp JG. Abstract 1064: STAT3 NH2-terminal domain inhibition sensitizes medulloblastoma cells to chemotherapy Cancer Research. 77: 1064-1064. DOI: 10.1158/1538-7445.Am2017-1064 |
0.371 |
|
| 2016 |
Coulter DW, McGuire TR, Sharp JG, McIntyre EM, Dong Y, Wang X, Gray S, Alexander GR, Chatuverdi NK, Joshi SS, Chen X, Vennerstrom JL. Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513. Bmc Cancer. 16: 867. PMID 27821095 DOI: 10.1186/S12885-016-2872-2 |
0.415 |
|
| 2016 |
Haney SL, Upchurch GM, Opavska J, Klinkebiel D, Appiah AK, Smith LM, Heavican TB, Iqbal J, Joshi S, Opavsky R. Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice. Scientific Reports. 6: 34222. PMID 27677595 DOI: 10.1038/Srep34222 |
0.475 |
|
| 2016 |
Shukla V, Shukla A, Joshi SS, Lu R. Interferon regulatory factor 4 attenuates notch signaling to suppress the development of chronic lymphocytic leukemia. Oncotarget. PMID 27232759 DOI: 10.18632/Oncotarget.9596 |
0.406 |
|
| 2016 |
Haney SL, Upchurch GM, Opavska J, Klinkebiel D, Hlady RA, Suresh A, Pirruccello SJ, Shukla V, Lu R, Costinean S, Rizzino A, Karpf AR, Joshi S, Swanson P, Opavsky R. Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a. Cell Reports. PMID 27134162 DOI: 10.1016/J.Celrep.2016.04.004 |
0.377 |
|
| 2016 |
Hassan HM, Varney ML, Chaturvedi NK, Joshi SS, Weisenburger DD, Singh RK, Dave BJ. Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status. Leukemia & Lymphoma. 1-16. PMID 27074052 DOI: 10.3109/10428194.2016.1165814 |
0.484 |
|
| 2016 |
Chaturvedi NK, McGuire TR, Coulter DW, Shukla A, McIntyre EM, Sharp JG, Joshi SS. Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecan. Oncotarget. PMID 26934655 DOI: 10.18632/Oncotarget.7714 |
0.433 |
|
| 2016 |
Shukla A, Rai K, Shukla V, Chaturvedi NK, Bociek RG, Pirruccello SJ, Band H, Lu R, Joshi SS. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL. Blood. PMID 26809508 DOI: 10.1182/Blood-2015-09-669317 |
0.524 |
|
| 2016 |
Chaturvedi NK, Timothy MR, Coulter DW, Shukla A, McIntyre EM, Sharp JG, Joshi SS. Abstract B05: Improved therapy for neuroblastoma using small molecule inhibitors in combination with chemotherapy Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-B05 |
0.465 |
|
| 2015 |
Shukla A, Cutucache CE, Sutton GL, Pitner MA, Rai K, Rai S, Opavsky R, Swanson PC, Joshi SS. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model. Experimental Hematology. PMID 26435347 DOI: 10.1182/Blood.V124.21.2196.2196 |
0.79 |
|
| 2015 |
Kumar S, Torres MP, Kaur S, Rachagani S, Joshi S, Johansson SL, Momi N, Baine MJ, Gilling CE, Smith LM, Wyatt TA, Jain M, Joshi SS, Batra SK. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Oncogene. 34: 2052-60. PMID 24909166 DOI: 10.1038/Onc.2014.154 |
0.302 |
|
| 2015 |
Shukla A, Shadoin M, Pirruccello S, Joshi SS. Mirna-21 Targets Sprouty2 to Activate SYK Mediated BCR and MAPK-Erk Signaling in Chronic Lymphocytic Leukemia Blood. 126: 4135-4135. DOI: 10.1182/Blood.V126.23.4135.4135 |
0.371 |
|
| 2015 |
Hassan HM, Varney ML, Aly AM, Joshi SS, Singh RK, Dave BJ. Abstract 2632: The COX inhibitor, diclofenac induces mantle cell lymphoma apoptosis independent of p53 status Cancer Research. 75: 2632-2632. DOI: 10.1158/1538-7445.Am2015-2632 |
0.467 |
|
| 2014 |
Mittal AK, Chaturvedi NK, Rai KJ, Gilling-Cutucache CE, Nordgren TM, Moragues M, Lu R, Opavsky R, Bociek GR, Weisenburger DD, Iqbal J, Joshi SS. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease. Molecular Medicine (Cambridge, Mass.). 20: 290-301. PMID 24800836 DOI: 10.2119/Molmed.2012.00303 |
0.795 |
|
| 2014 |
Shukla V, Ma S, Joshi S, Lu R. Notch2 Is Critical for CLL Development in the IRF4-/-Vh11 Mice Blood. 124: 891-891. DOI: 10.1182/Blood.V124.21.891.891 |
0.407 |
|
| 2014 |
Shukla A, Rai K, Bociek G, Pirruccello SJ, Lu R, Joshi S. Role of Sprouty2 in the Pathogenesis of Chronic Lymphocytic Leukemia Blood. 124: 719-719. DOI: 10.1182/Blood.V124.21.719.719 |
0.587 |
|
| 2013 |
Chaturvedi NK, Rajule RN, Shukla A, Radhakrishnan P, Todd GL, Natarajan A, Vose JM, Joshi SS. Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach. Molecular Cancer Therapeutics. 12: 2006-17. PMID 23963361 DOI: 10.1158/1535-7163.Mct-13-0239 |
0.539 |
|
| 2013 |
Mittal AK, Chaturvedi NK, Rohlfsen RA, Gupta P, Joshi AD, Hegde GV, Bociek RG, Joshi SS. Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia. Plos One. 8: e70352. PMID 23936412 DOI: 10.1371/Journal.Pone.0070352 |
0.749 |
|
| 2013 |
Shukla V, Ma S, Hardy RR, Joshi SS, Lu R. A role for IRF4 in the development of CLL. Blood. 122: 2848-55. PMID 23926303 DOI: 10.1182/Blood-2013-03-492769 |
0.5 |
|
| 2013 |
Ma S, Shukla V, Fang L, Gould KA, Joshi SS, Lu R. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4. The Journal of Biological Chemistry. 288: 26430-40. PMID 23897826 DOI: 10.1074/Jbc.M113.475913 |
0.453 |
|
| 2013 |
Peters HL, Yan Y, Nordgren TM, Cutucache CE, Joshi SS, Solheim JC. Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells. Cancer Biology & Therapy. 14: 752-60. PMID 23792571 DOI: 10.4161/Cbt.25183 |
0.825 |
|
| 2013 |
Cutucache CE, Iqbal J, Bierman PJ, Bociek RG, Weisenburger DD, Joshi SS. Polycomb response element-binding sites in the MDR of CLL: Potential tumor suppressor regulation Advances in Bioscience and Biotechnology. 4: 129-135. DOI: 10.4236/Abb.2013.41A019 |
0.742 |
|
| 2013 |
Shukla A, Chaturvedi NK, Joshi SS, Bierman P, Cornish A, Pandey S, Guda C. The Role Of PRDM1 and Its Interacting Proteins In The Pathogenesis Of Chronic Lymphocytic Leukemia Blood. 122: 2865-2865. DOI: 10.1182/Blood.V122.21.2865.2865 |
0.508 |
|
| 2013 |
Ahrens AK, Chaturvedi NK, Shukla A, Nordgren TM, Hegde GV, Vose JM, Joshi SS. Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma Lymphoma. 2013: 1-10. DOI: 10.1155/2013/782903 |
0.702 |
|
| 2012 |
Gilling CE, Mittal AK, Chaturvedi NK, Iqbal J, Aoun P, Bierman PJ, Bociek RG, Weisenburger DD, Joshi SS. Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1. British Journal of Haematology. 158: 216-31. PMID 22571278 DOI: 10.1111/J.1365-2141.2012.09148.X |
0.64 |
|
| 2012 |
Ahrens AK, Chaturvedi NK, Nordgren TM, Dave BJ, Joshi SS. Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from different tissue sites. Leukemia & Lymphoma. 53: 2269-78. PMID 22568512 DOI: 10.3109/10428194.2012.691481 |
0.718 |
|
| 2012 |
Hegde GV, Nordgren TM, Munger CM, Mittal AK, Bierman PJ, Weisenburger DD, Vose JM, Sharp JG, Joshi SS. Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling. International Journal of Cancer. Journal International Du Cancer. 131: 2951-60. PMID 22511234 DOI: 10.1002/Ijc.27602 |
0.811 |
|
| 2012 |
Munger CM, Hegde GV, Weisenburger DD, Vose JM, Joshi SS. Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma. Cancer Immunology, Immunotherapy : Cii. 61: 1819-32. PMID 22441656 DOI: 10.1007/S00262-012-1229-1 |
0.836 |
|
| 2012 |
Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J, Hannah J, Iqbal J, Anderson KM, Siebler HM, Smith LM, Greiner TC, Bastola D, Joshi S, Lockridge O, et al. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. The Journal of Clinical Investigation. 122: 163-77. PMID 22133874 DOI: 10.1172/Jci57292 |
0.395 |
|
| 2012 |
Gabius S, Joshi S, Kayser K, Gabius H. The galactoside-specific lectin from mistletoe as biological response modifier. International Journal of Oncology. 1: 705-8. PMID 21584604 DOI: 10.3892/ijo.1.6.705 |
0.387 |
|
| 2012 |
Joshi S, Wu A, Verbik D, Algarra S, Bishop M, Pirruccello S, Iversen P, Jackson J, Kessinger M, Sharp J. Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cells. International Journal of Oncology. 8: 815-20. PMID 21544432 DOI: 10.3892/Ijo.8.4.815 |
0.338 |
|
| 2012 |
Nordgren TM, Hegde GV, Joshi SS. Ritonavir exhibits limited efficacy as a single agent in treating aggressive mantle cell lymphoma Journal of Cancer Science and Therapy. 4: 61-68. DOI: 10.4172/1948-5956.1000112 |
0.727 |
|
| 2012 |
Shukla V, Ma S, Uehling M, Joshi SS, Lu R. A Role for Interferon Regulatory Factor 4 in the Development of CLL Blood. 120: 714-714. DOI: 10.1182/Blood.V120.21.714.714 |
0.503 |
|
| 2012 |
Chaturvedi NK, Rajule R, Ashima S, Radhakrishnan P, Natarajan A, Vose JM, Joshi SS. Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Targeting NF-κB and mTOR Signaling Pathways in Vitro and in Vivo Blood. 120: 63-63. DOI: 10.1182/Blood.V120.21.63.63 |
0.525 |
|
| 2012 |
Chaturvedi NK, Ahrens AK, Shukla A, Gilling CE, Mittal AK, Bierman P, Weisenburger DD, Lu R, Joshi SS. Stromal Tumor Microenvironment in CLL: Regulation of Leukemic Progression Blood. 120: 1781-1781. DOI: 10.1182/Blood.V120.21.1781.1781 |
0.636 |
|
| 2012 |
Hassan HM, Varney ML, Joshi SS, Singh RK, Dave BJ. Abstract 1180: Modulation of p73 isoform expression regulates aggressive behavior in NHL cell line model with 1p36 chromosomal disruption Cancer Research. 72: 1180-1180. DOI: 10.1158/1538-7445.Am2012-1180 |
0.474 |
|
| 2011 |
Pathak S, Ma S, Trinh L, Eudy J, Wagner KU, Joshi SS, Lu R. IRF4 is a suppressor of c-Myc induced B cell leukemia. Plos One. 6: e22628. PMID 21818355 DOI: 10.1371/Journal.Pone.0022628 |
0.514 |
|
| 2011 |
Kollessery G, Nordgren TM, Mittal AK, Joshi SS, Sanderson SD. Tumor-specific peptide-based vaccines containing the conformationally biased, response-selective C5a agonists EP54 and EP67 protect against aggressive large B cell lymphoma in a syngeneic murine model. Vaccine. 29: 5904-10. PMID 21723901 DOI: 10.1016/J.Vaccine.2011.06.070 |
0.726 |
|
| 2011 |
Trickler WJ, Munt DJ, Jain N, Joshi SS, Dash AK. Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel. Nanomedicine (London, England). 6: 437-48. PMID 21542683 DOI: 10.2217/Nnm.10.135 |
0.322 |
|
| 2011 |
Mittal AK, Iqbal J, Gilling CE, Moragues M, Bociek RG, Aoun P, Weisenburger DD, Joshi SS. The Aggressive Molecular Signature of Peripheral Blood Chronic Lymphocytic Leukemia (CLL) Cells From Patients with Bulky Lymphadenopathy Closely Resembles That of CLL Cells From Lymph Nodes, Blood. 118: 3868-3868. DOI: 10.1182/Blood.V118.21.3868.3868 |
0.646 |
|
| 2011 |
Gupta P, Mittal AK, Weisenburger DD, Bierman P, Joshi SS. Heat-Shock Protein Signature Is Associated with Refractory Chronic Lymphocytic Leukemia Cells From Different In Vivo Microenvironments, Blood. 118: 3866-3866. DOI: 10.1182/Blood.V118.21.3866.3866 |
0.596 |
|
| 2011 |
Hassan HM, Varney ML, Jain S, Joshi SS, Singh RK, Dave BJ. Abstract 222: Differential p73 isoform expression profile in non-Hodgkin's lymphoma with 1p36 chromosomal abnormality modulates angiogenic phenotype Cancer Research. 71: 222-222. DOI: 10.1158/1538-7445.Am2011-222 |
0.378 |
|
| 2010 |
Clark EM, Joshi DS, Grimm AB, Joshi AD, Wang P, Joshi SS. Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: a comparative analysis with peripheral blood and bone marrow. International Journal of Oncology. 37: 645-53. PMID 20664933 DOI: 10.3892/Ijo-00000713 |
0.612 |
|
| 2010 |
Nordgren TM, Joshi SS. The Etiology of Chronic Lymphocytic Leukemia: Another Look at the Relationship Between B1 cells and CLL The Open Leukemia Journal. 3. DOI: 10.2174/1876816401003010069 |
0.729 |
|
| 2010 |
Nordgren, TM, Hegde G, Munger C, Vose JM, Joshi S. Targeting the PI3K/AKT/Survivin Pathway with Ritonavir In Therapy-Resistant Mantle Cell Lymphoma Blood. 116: 2855-2855. DOI: 10.1182/Blood.V116.21.2855.2855 |
0.832 |
|
| 2010 |
Gilling C, Mittal A, Nganga V, Palmer V, Weisenburger DD, Bierman P, Bociek RG, Swanson P, Joshi S. Molecular Determinants of Lymph Node Microenvironment Induced Host Immune Tolerance In CLL: Role for CAV1, PTPN6, and PKCβ In the Process Blood. 116: 1367-1367. DOI: 10.1182/Blood.V116.21.1367.1367 |
0.624 |
|
| 2009 |
Mittal AK, Gilling CE, Iqbal J, Bociek RG, Aoun P, Bierman P, Joshi SS. Clinical Heterogeneity of CLL: Role for Immune Dysregulation Mediated by the Lymph Node Microenvironment. Blood. 114: 1243-1243. DOI: 10.1182/Blood.V114.22.1243.1243 |
0.608 |
|
| 2008 |
Hegde GV, Peterson KJ, Emanuel K, Mittal AK, Joshi AD, Dickinson JD, Kollessery GJ, Bociek RG, Bierman P, Vose JM, Weisenburger DD, Joshi SS. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Molecular Cancer Research : McR. 6: 1928-36. PMID 19074837 DOI: 10.1158/1541-7786.Mcr-08-0142 |
0.772 |
|
| 2008 |
Joshi SS, Mittal AK, Wang P, Joshi AD, Vu E, Wang X. Differential gene expression in murine large cell B-cell lymphoma metastatic variants. International Immunopharmacology. 8: 1257-63. PMID 18602072 DOI: 10.1016/J.Intimp.2008.05.007 |
0.762 |
|
| 2008 |
Hegde GV, Munger CM, Emanuel K, Joshi AD, Greiner TC, Weisenburger DD, Vose JM, Joshi SS. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Molecular Cancer Therapeutics. 7: 1450-60. PMID 18524848 DOI: 10.1158/1535-7163.Mct-07-2118 |
0.827 |
|
| 2008 |
Hegde GV, Meyers-Clark E, Joshi SS, Sanderson SD. A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells. International Immunopharmacology. 8: 819-27. PMID 18442785 DOI: 10.1016/J.Intimp.2008.01.031 |
0.344 |
|
| 2008 |
Mittal AK, Iqbal J, Nordgren TM, Moragues M, Bociek RG, Aoun P, Weisenburger DD, Joshi S. Molecular Basis of Proliferation/Survival and Migration of CLL in Peripheral Blood, Bone Marrow and Lymph Nodes Blood. 112: 546-546. DOI: 10.1182/Blood.V112.11.546.546 |
0.792 |
|
| 2008 |
Hegde GV, Nordgren TM, Munger CM, Mittal AK, Bierman PJ, Weisenburger DD, Sharp G, Vose JM, Joshi S. Characterization and Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Isolated from Liver and Kidney Blood. 112: 2622-2622. DOI: 10.1182/Blood.V112.11.2622.2622 |
0.834 |
|
| 2008 |
Kollessery GJ, Nordgren TM, Mittal AK, Hegde GV, Sanderson SD, Joshi SS. Development of Vaccine-Based Immunotherapy for Murine Large B-Cell Lymphoma Blood. 112: 2619-2619. DOI: 10.1182/Blood.V112.11.2619.2619 |
0.717 |
|
| 2007 |
Joshi AD, Clark EM, Wang P, Munger CM, Hegde GV, Sanderson S, Dave HP, Joshi SS. Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 202-12. PMID 18040845 DOI: 10.1007/S11481-006-9038-Y |
0.826 |
|
| 2007 |
Iqbal J, Joshi S, Patel KN, Javed SI, Kucuk C, Aabida A, d'Amore F, Fu K. Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma. Indian Journal of Cancer. 44: 72-86. PMID 17938484 DOI: 10.4103/0019-509X.35814 |
0.388 |
|
| 2007 |
Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, Eudy JD, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5295-304. PMID 17875758 DOI: 10.1158/1078-0432.Ccr-07-0283 |
0.728 |
|
| 2007 |
Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. International Journal of Molecular Medicine. 20: 461-9. PMID 17786276 DOI: 10.3892/Ijmm.20.4.461 |
0.699 |
|
| 2007 |
Joshi AD, Dickinson JD, Hegde GV, Sanger WG, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS. Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion. Cancer Genetics and Cytogenetics. 172: 120-6. PMID 17213020 DOI: 10.1016/J.Cancergencyto.2006.07.010 |
0.655 |
|
| 2007 |
Hegde GV, Peterson KJ, Emanuel K, Mittal AK, Bociek RG, Weisenburger DD, Joshi SS. GLI1 Transcription Factor: A Potential Therapeutic Target in B-CLL. Blood. 110: 3100-3100. DOI: 10.1182/Blood.V110.11.3100.3100 |
0.65 |
|
| 2007 |
Joshi SS, Munger CM, Hegde GV, Weisenburger DD, Vose JM. Therapeutic Effectiveness of Adaptive T-Cell Transfer for Minimal Residual Mantle Cell Lymphoma Following High Dose Therapy. Blood. 110: 2760-2760. DOI: 10.1182/Blood.V110.11.2760.2760 |
0.833 |
|
| 2007 |
Mittal AK, Rohlfsen RA, Joshi AD, Hegde GV, Bociek RG, Joshi SS. Regulation of Chronic Lymphocytic Leukemia Cell Proliferation by CTLA4. Blood. 110: 1140-1140. DOI: 10.1182/Blood.V110.11.1140.1140 |
0.753 |
|
| 2007 |
Mittal AK, Clark EM, Joshi DS, Grimm AB, Gordon B, Coccia P, Joshi SS. Irradiation of umbilical cord blood derived Lymphokine Activated Killer (LAK) cells prevents GVHD while maintaining an antitumor effect in vivo The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A229-B |
0.547 |
|
| 2007 |
Hegde G, Munger C, Emanuel K, Weisenburger D, Joshi A, Vose J, Joshi S. Targeting Conic Hedgehog-GLI Signaling for the Treatment of Mantle Cell Lymphoma Clinical Immunology. 123: S109. DOI: 10.1016/J.Clim.2007.03.490 |
0.797 |
|
| 2007 |
Bociek R, Talmadge J, Loberiza F, Kuszynski C, Bierman P, Vose J, Devetten M, Maness L, Armitage J, Joshi S, Wisecarver J, Enke C, McGuire T, Bernal K, Pavletic S. 228: Nonmyeloablative allogeneic stem cell transplantation (NST) for hematologic malignancies (HM) using pentostatin/low-dose total body irradiation (Pt-TBI) Biology of Blood and Marrow Transplantation. 13: 83-84. DOI: 10.1016/J.Bbmt.2006.12.233 |
0.311 |
|
| 2006 |
Chakravarti D, Zahid M, Backora M, Myers EM, Gaikwad N, Weisenburger DD, Cavalieri EL, Rogan EG, Joshi SS. Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells. Leukemia & Lymphoma. 47: 2635-44. PMID 17169809 DOI: 10.1080/10428190600931937 |
0.42 |
|
| 2006 |
Munger CM, Vose JM, Joshi SS. Dendritic cell-based therapy for mantle cell lymphoma. International Journal of Oncology. 28: 1337-43. PMID 16685434 DOI: 10.1016/J.Clim.2007.03.489 |
0.827 |
|
| 2006 |
Dickinson JD, Joshi A, Iqbal J, Sanger W, Bierman PJ, Joshi SS. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect. International Journal of Molecular Medicine. 17: 769-78. PMID 16596259 DOI: 10.3892/Ijmm.17.5.769 |
0.592 |
|
| 2006 |
Dickinson JD, Gilmore J, Iqbal J, Sanger W, Lynch JC, Chan J, Bierman PJ, Joshi SS. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules. Leukemia & Lymphoma. 47: 231-44. PMID 16321852 DOI: 10.1080/10428190500254141 |
0.414 |
|
| 2006 |
Hegde GV, Emanuel K, Joshi AD, Munger CM, Weisenburger DD, Vose JM, Joshi SS. Sonic Hedgehog Signaling in Mantle Cell Lymphoma. Blood. 108: 2046-2046. DOI: 10.1182/Blood.V108.11.2046.2046 |
0.832 |
|
| 2005 |
Dickinson JD, Smith LM, Sanger WG, Zhou G, Townley P, Lynch JC, Pavletic ZS, Bierman PJ, Joshi SS. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia. British Journal of Haematology. 128: 460-71. PMID 15686453 DOI: 10.1111/J.1365-2141.2004.05344.X |
0.382 |
|
| 2005 |
Bociek RG, Talmadge JE, Lynch JC, Enke CA, Kuszynski CA, Bierman PJ, Vose JM, Armitage JO, Devetten MP, Maness LJ, McGuire TR, Wisecarver JL, Joshi SS, Pavletic ZS. Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI). Blood. 106: 3671-3671. DOI: 10.1182/Blood.V106.11.3671.3671 |
0.344 |
|
| 2005 |
Joshi AD, Dickinson JD, Lynch JC, Bierman PJ, Bociek GR, Devetten MP, Armitage JO, Joshi SS. Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression. Blood. 106: 2103-2103. DOI: 10.1182/Blood.V106.11.2103.2103 |
0.627 |
|
| 2004 |
Wang P, Munger CM, Joshi AD, Pirruccello SJ, Joshi SS. Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo. Breast Cancer Research and Treatment. 83: 15-23. PMID 14997051 DOI: 10.1023/B:Brea.0000010688.55353.A8 |
0.801 |
|
| 2004 |
Dickinson JD, Joshi A, Gilmore J, Bierman PJ, Warren S, Joshi SS. Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion. Blood. 104: 971-971. DOI: 10.1182/Blood.V104.11.971.971 |
0.64 |
|
| 2004 |
Bociek G, Pavletic S, Foran J, Rubocki R, Kuszynski C, Lynch J, Bierman P, Vose J, Armitage J, Joshi S, Talmadge J, Enke C, Wisecarver J, McGuire T. Nonmyeloablative allogeneic stem cell transplantation (NST) for lymphoid malignancies using pentostatin/low-dose total body irradiation Biology of Blood and Marrow Transplantation. 10: 27. DOI: 10.1016/J.Bbmt.2003.12.109 |
0.32 |
|
| 2003 |
Pavletic SZ, Bociek RG, Foran JM, Rubocki RJ, Kuszynski CA, Wisecarver JL, Hatcher L, Lucas DM, Byrd JC, Grever MR, Joshi SS, Hardiman P, Smith LM, McGuire TR, Bierman PJ, et al. Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation. Transplantation. 76: 877-81. PMID 14501873 DOI: 10.1097/01.Tp.0000084869.08639.A0 |
0.378 |
|
| 2003 |
Bhattacharya S, Jackson JD, Das AV, Thoreson WB, Kuszynski C, James J, Joshi S, Ahmad I. Direct identification and enrichment of retinal stem cells/progenitors by Hoechst dye efflux assay. Investigative Ophthalmology & Visual Science. 44: 2764-73. PMID 12766085 DOI: 10.1167/Iovs.02-0899 |
0.391 |
|
| 2003 |
Murphy BO, Joshi S, Kessinger A, Reed E, Sharp JG. A murine model of bone marrow micrometastasis in breast cancer. Clinical & Experimental Metastasis. 19: 561-9. PMID 12498385 DOI: 10.1023/A:1020958915361 |
0.465 |
|
| 2002 |
Wang P, Pavletic ZS, Joshi SS. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation. Leukemia & Lymphoma. 43: 1827-35. PMID 12685840 DOI: 10.1080/1042819021000006411 |
0.508 |
|
| 2002 |
Joshi SS, Vu UE, Lovgren TR, Lorkovic M, Patel W, Todd GL, Kuszynski C, Joshi BJ, Dave HP. Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells. Journal of Hematotherapy & Stem Cell Research. 11: 337-47. PMID 11983105 DOI: 10.1089/152581602753658529 |
0.417 |
|
| 2001 |
Sharp JG, Bishop MR, Copple B, Greiner TC, Iversen PL, Jackson JD, Joshi SS, Benner EJ, Mann SL, Rao AK, Vose JM. Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. Leukemia & Lymphoma. 42: 417-27. PMID 11699407 DOI: 10.3109/10428190109064599 |
0.504 |
|
| 2001 |
Joshi SS, Lynch JC, Pavletic SZ, Tarantolo SR, Pirruccello SJ, Kessinger A, Bishop MR. Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics. Blood. 98: 1963-70. PMID 11535536 DOI: 10.1182/Blood.V98.6.1963 |
0.436 |
|
| 2001 |
Joshi SS, Kuszynski CA, Bagchi D. The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Current Pharmaceutical Biotechnology. 2: 187-200. PMID 11480422 DOI: 10.2174/1389201013378725 |
0.386 |
|
| 2001 |
Joshi SS, Lovgren TR, Wang P, Tarantolo SR. Generation of cytokine activated antigen non-specific and dendritic cell primed Her2/neu peptide specific cytotoxic T cells from cord blood against human breast cancer Breast Cancer Research and Treatment. 69: 311. |
0.357 |
|
| 2000 |
Joshi SS, Miller K, Jackson JD, Warkentin P, Kessinger A. Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients. Cytotherapy. 2: 15-24. PMID 12042051 DOI: 10.1080/146532400539017 |
0.466 |
|
| 2000 |
Vu UE, Pavletic ZS, Wang X, Joshi SS. Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: potentials for therapeutic use. Leukemia & Lymphoma. 39: 573-82. PMID 11342340 DOI: 10.3109/10428190009113387 |
0.495 |
|
| 2000 |
Sharp JG, Kessinger A, Lynch JC, Pavletic ZS, Joshi SS. Blood stem cell transplantation: factors influencing cellular immunological reconstitution. Journal of Hematotherapy & Stem Cell Research. 9: 971-81. PMID 11177612 DOI: 10.1089/152581600750062435 |
0.443 |
|
| 2000 |
Joshi SS, Kuszynski CA, Bagchi M, Bagchi D. Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cells. Toxicology. 155: 83-90. PMID 11154800 DOI: 10.1016/S0300-483X(00)00280-8 |
0.514 |
|
| 2000 |
Bagchi D, Joshi SS, Bagchi M, Balmoori J, Benner EJ, Kuszynski CA, Stohs SJ. Cadmium- and chromium-induced oxidative stress, DNA damage, and apoptotic cell death in cultured human chronic myelogenous leukemic K562 cells, promyelocytic leukemic HL-60 cells, and normal human peripheral blood mononuclear cells. Journal of Biochemical and Molecular Toxicology. 14: 33-41. PMID 10561080 DOI: 10.1002/(Sici)1099-0461(2000)14:1<33::Aid-Jbt5>3.0.Co;2-Y |
0.435 |
|
| 1999 |
Joshi SS, Kuszynski CA, Benner EJ, Bagchi M, Bagchi D. Amelioration of the cytotoxic effects of chemotherapeutic agents by grape seed proanthocyanidin extract. Antioxidants & Redox Signaling. 1: 563-70. PMID 11233153 DOI: 10.1089/Ars.1999.1.4-563 |
0.491 |
|
| 1999 |
Ye X, Krohn R, Liu W, Joshi S, Kuszynski C, McGinn T, Bagchi M, Preuss H, Stohs S, Bagchi D. Molecular and Cellular Biochemistry. 196: 99-108. DOI: 10.1023/A:1006926414683 |
0.448 |
|
| 1998 |
Joshi SS, Babushkina-Patz NN, Verbik DJ, Gross TG, Tarantolo SR, Kuszynski CA, Pirruccello SJ, Bishop MR, Kessinger A. Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells. International Journal of Oncology. 13: 791-9. PMID 9735410 DOI: 10.3892/Ijo.13.4.791 |
0.514 |
|
| 1998 |
Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC, Bierman PJ, Vose JM, Warkentin PI, Gross TG, Nasrati K, Armitage JO, Kessinger A, Bishop MR. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplantation. 21: 33-41. PMID 9486492 DOI: 10.1038/Sj.Bmt.1701037 |
0.409 |
|
| 1998 |
Schneiderman MH, Jackson JD, Joshi SS, Clark-Pierce L, Murphy BJ, Schneiderman GS. Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine. Radiation Research. 149: 147-154. DOI: 10.2307/3579924 |
0.437 |
|
| 1997 |
Benner E, Bishop MR, Agarwal N, Iversen P, Joshi SS. Combination of antisense oligonucleotide and low-dose chemotherapy in hematological malignancies. Journal of Pharmacological and Toxicological Methods. 37: 229-35. PMID 9279778 DOI: 10.1016/S1056-8719(97)00034-8 |
0.474 |
|
| 1997 |
Mann SL, Joshi SS, Crouse DA, Armitage JO, Kessinger A, Weisenburger DD, Vaughan WP, Sharp JG. Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells. Breast Cancer Research and Treatment. 44: 115-21. PMID 9232270 DOI: 10.1023/A:1005732531318 |
0.42 |
|
| 1997 |
Hao W, Messbarger L, Joshi SS. Immunosuppression by metastatic lymphoma derived altered retroviral gp70 molecule. Leukemia. 11: 202-5. PMID 9209341 |
0.373 |
|
| 1997 |
Mata JE, Joshi SS, Palen B, Pirruccello SJ, Jackson JD, Elias N, Page TJ, Medlin KL, Iversen PL. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicology and Applied Pharmacology. 144: 189-97. PMID 9169084 DOI: 10.1006/Taap.1997.8103 |
0.418 |
|
| 1997 |
Rao AK, Kuszynski CA, Benner E, Iversen PL, Jackson JD, Bishop MR, Joshi SS. Increased growth inhibition of human chronic myelogenous leukemic cells by a combination of c-myb antisense oligonucleotide and 4- hydroxyperoxycyclophosphamide in vitro International Journal of Oncology. 11: 281-287. DOI: 10.3892/Ijo.11.2.281 |
0.353 |
|
| 1996 |
Verbik DJ, Stinson WW, Brunda MJ, Kessinger A, Joshi SS. In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma. Clinical & Experimental Metastasis. 14: 219-29. PMID 8674276 DOI: 10.1007/Bf00053895 |
0.399 |
|
| 1995 |
Verbik DJ, Joshi SS. Immune cells and cytokines - their role in cancer-immunotherapy (review). International Journal of Oncology. 7: 205-223. PMID 21552827 DOI: 10.3892/Ijo.7.2.205 |
0.504 |
|
| 1995 |
Wu AG, Joshi SS, Chan WC, Iversen PL, Jackson JD, Kessinger A, Pirruccello SJ, Sanger WG, Sharp JG, Verbik DJ. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents. Leukemia & Lymphoma. 20: 67-76. PMID 8750625 DOI: 10.3109/10428199509054755 |
0.485 |
|
| 1995 |
Komanduri KC, Tomes DJ, Gabius HJ, Joshi SS. Macrophage-like-cell-induced growth regulation of lymphoma cells. Oncology. 52: 196-201. PMID 7715903 DOI: 10.1159/000227457 |
0.461 |
|
| 1995 |
Joshi SS, Connolly J, Mann SL, Sharp JG. Altered in vivo and in vitro behavior of butanol-modified bone marrow cells. Experimental Hematology. 23: 1284-8. PMID 7589283 |
0.378 |
|
| 1995 |
Verbik D, Jackson J, Pirruccello S, Patil K, Kessinger A, Joshi S. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections Blood. 85: 1964-1970. DOI: 10.1182/Blood.V85.7.1964.Bloodjournal8571964 |
0.518 |
|
| 1995 |
Verbik DJ, Joshi SS. Immune cells and cytokines: Their role in cancer immunotherapy International Journal of Oncology. 7: 205-223. |
0.408 |
|
| 1994 |
Joshi SS, Messbarger LJ, Hao W. Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice. Clinical & Experimental Metastasis. 12: 37-46. PMID 8287619 DOI: 10.1007/Bf01784332 |
0.449 |
|
| 1994 |
Gabius HJ, Gabius S, Joshi SS, Koch B, Schroeder M, Manzke WM, Westerhausen M. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe? Planta Medica. 60: 2-7. PMID 8134410 DOI: 10.1055/S-2006-959396 |
0.398 |
|
| 1994 |
Kessinger A, Armitage J, Bierman P, Bishop M, Joshi S, Reed E, Sharp G, Talmadge J, Vose J. Clinical outcome of peripheral blood stem cell support Medical Oncology. 11: 43-46. PMID 7850263 DOI: 10.1007/Bf02988829 |
0.391 |
|
| 1994 |
Kefu W, Luka J, Joshi SS, Pirruccello SJ, Masih A, Graham Sharp J. Characterization of a human herpes virus-6 (HHV-6) and epstein-barr virus (EBV) associated leukemic cell line, J6-1 Chinese Journal of Cancer Research. 6: 157-168. DOI: 10.1007/Bf02672267 |
0.483 |
|
| 1993 |
Hao W, McDonald TL, Brunson KW, Joshi SS. Enhanced immunosuppressive activity associated with metastatic lymphoma cells. Cancer Research. 53: 1921-8. PMID 8385575 |
0.375 |
|
| 1993 |
Saxena SK, Thompson JS, Joshi SS, Sharp JG. Extent and role of urogastrone in the adaptive response of rat intestine to patching of a surgical defect in the ileum. Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research. 6: 485-92. PMID 8123609 DOI: 10.3109/08941939309141638 |
0.3 |
|
| 1992 |
Joshi SS, Mann SL, Tempero MA, Crouse DA, Stratbucker RA, Quaife MA, Sharp JG. Quantitation of metastatic tumor burden from human colon tumor xenografts using radiolabelled monoclonal antibody 17-A fragments. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 13: 195-206. PMID 1411138 DOI: 10.1159/000217766 |
0.319 |
|
| 1992 |
Sharp J, Joshi S, Armitage J, Bierman P, Coccia P, Harrington D, Kessinger A, Crouse D, Mann S, Weisenburger D. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique Blood. 79: 1074-1080. DOI: 10.1182/Blood.V79.4.1074.Bloodjournal7941074 |
0.437 |
|
| 1991 |
Joshi SS, O'Connor SJ, Weisenburger DD, Sharp JG, Gharpure HM, Brunson KW. Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells. Clinical & Experimental Metastasis. 9: 27-37. PMID 2015714 DOI: 10.1007/Bf01831707 |
0.515 |
|
| 1991 |
Joshi SS, DeBoer JM, Strandjord SJ, Pirruccello SJ, Sanger WG, Weisenburger DD, Sharp JG. Characterization of a newly established human Burkitt's lymphoma cell line, OMA-BL-1. International Journal of Cancer. Journal International Du Cancer. 47: 643-8. PMID 1848532 DOI: 10.1002/Ijc.2910470502 |
0.526 |
|
| 1991 |
Gabius S, Joshi SS, Gabius HJ, Sharp JG. Establishment, characterization and determination of cell surface sugar receptor (lectin) expression by neoglycoenzymes of a human myeloid marker-expressing B lymphoblastoid cell line. Anticancer Research. 11: 793-800. PMID 1712180 |
0.361 |
|
| 1990 |
Gabius S, Schirrmacher V, Franz H, Joshi SS, Gabius HJ. Analysis of cell-surface sugar receptor expression by neoglycoenzyme binding and adhesion to plastic-immobilized neoglycoproteins for related weakly and strongly metastatic cell lines of murine tumor model systems. International Journal of Cancer. Journal International Du Cancer. 46: 500-7. PMID 2168345 DOI: 10.1002/Ijc.2910460329 |
0.439 |
|
| 1990 |
Hao WM, Joshi SS. Differential susceptibility of metastatic lymphoma cells to natural immunity. Oncology. 47: 483-7. PMID 2123024 DOI: 10.1159/000226877 |
0.512 |
|
| 1990 |
Joshi SS, Brunson KW. Differential cell surface antigen expression on metastatic variant lymphoma cell lines. Oncology. 47: 339-43. PMID 1694982 DOI: 10.1159/000226845 |
0.494 |
|
| 1990 |
Alter R, Joshi SS, Verdirame JD, Weisenburger DD. Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. Leukemia Research. 14: 279-86. PMID 1690829 DOI: 10.1016/0145-2126(90)90136-W |
0.439 |
|
| 1989 |
Joshi SS, Jackson JD, Sharp JG. Comparison of the growth and metastasis of four human intestinal tumor cell line xenografts. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 10: 117-25. PMID 2762735 DOI: 10.1159/000217607 |
0.376 |
|
| 1988 |
Joshi SS, Glenn LD, Vaughan WP, Stevenson M, Sanger WG, Sharp JG, Weisenburger DD. Preferential in-vitro growth and expansion of leukemic T lymphoblasts. Leukemia Research. 12: 103-8. PMID 2965777 DOI: 10.1016/0145-2126(88)90068-9 |
0.39 |
|
| 1987 |
Joshi SS, Sharp JG, Brunson KW. Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells. Oncology. 44: 180-5. PMID 3601320 DOI: 10.1159/000226473 |
0.472 |
|
| 1987 |
Joshi SS, Sharp JG, Gharpure HM, Brunson KW. Characterization of metastasis-associated antigens on RAW117 lymphosarcoma cell lines. Clinical & Experimental Metastasis. 5: 89-104. PMID 3103962 DOI: 10.1007/Bf00116629 |
0.407 |
|
| Show low-probability matches. |